Comparative expression of immunohistochemical biomarkers in cribriform and pattern 4 non-cribriform prostatic adenocarcinoma-Reference-Cited by-同舟云学术

Comparative expression of immunohistochemical biomarkers in cribriform and pattern 4 non-cribriform prostatic adenocarcinoma

Published:2020-06 Issue: Volume:114 Page:104400
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Xiao Guang-Qian,Nguyen Elise,Unger Pamela D.,Sherrod Andy E.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference53 articles.

1. Genomic correlates of clinical outcome in advanced prostate cancer;Abida;Proc. Natl. Acad. Sci. U. S. A.,2019

2. Correlation of AR, EGFR, and HER2 expression levels in prostate cancer: immunohistochemical analysis and chromogenic in situ hybridization;Baek;Cancer Res. Treat.,2012

3. The loss of CD44 and HSP70 overexpression is related to aggressive clinicopathologic factors in prostate cancer;Baek;Int. J. Clin. Exp. Pathol.,2018

4. Overexpression of specific CD44 isoforms is associated with aggressive cell features in acquired endocrine resistance;Bellerby;Front. Oncol.,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management;Urologic Oncology: Seminars and Original Investigations;2024-05

2. NKX3.1 Expression in Non-Prostatic Tumors and Characterizing its Expression in Esophageal/Gastroesophageal Adenocarcinoma;Advances in Anatomic Pathology;2024-03-25

3. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions;Cancers;2022-12-14

4. Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease;Nature Communications;2022-10-13

5. Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance;Cancers;2022-06-21